GAIN THERAPEUTICS, INC Increase (Decrease) in Other Noncurrent Assets
GAIN THERAPEUTICS, INC (GANX) reported Increase (Decrease) in Other Noncurrent Assets of -$9.85 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-11
- GAIN THERAPEUTICS, INC increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was -$10.77K.
- GAIN THERAPEUTICS, INC increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was $913.00.
- GAIN THERAPEUTICS, INC increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was -$533.00.
- GAIN THERAPEUTICS, INC increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was -$541.00, a 103.25% decline year-over-year.
- GAIN THERAPEUTICS, INC increase (decrease) in other noncurrent assets for fiscal 2025 was -$2.85K, a 113.58% decline from fiscal 2024.
- GAIN THERAPEUTICS, INC increase (decrease) in other noncurrent assets for fiscal 2024 was $21.00K, a 108.81% increase from fiscal 2023.
- GAIN THERAPEUTICS, INC increase (decrease) in other noncurrent assets for fiscal 2023 was $10.06K, a 246.67% increase from fiscal 2022.
- GAIN THERAPEUTICS, INC increase (decrease) in other noncurrent assets for fiscal 2022 was $2.90K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 9 month as first filed | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$10.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$9.85K 10-Q · filed 2026-08-11 | -$10.39K derived: sum of 3 quarters · filed 2026-08-11 | -$10.93K derived: sum of 4 quarters · filed 2026-08-11 | |
| 2026-03-31 | $913.00 10-Q · filed 2026-05-11 | $380.00 derived: sum of 2 quarters · filed 2026-05-11 | -$161.00 derived: sum of 3 quarters · filed 2026-05-11 | -$1.01K derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-12-31 | -$533.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$1.07K derived: sum of 2 quarters · filed 2026-03-26 | -$1.93K derived: sum of 3 quarters · filed 2026-08-11 | -$2.85K 10-K · filed 2026-03-26 | |
| 2025-09-30 | -$541.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$1.39K derived: sum of 2 quarters · filed 2026-08-11 | -$2.32K 10-Q · filed 2025-11-12 | -$3.47K derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-06-30 | -$851.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$1.78K 10-Q · filed 2026-08-11 | -$2.93K derived: sum of 3 quarters · filed 2026-08-11 | $13.72K derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-03-31 | -$927.00 10-Q · filed 2026-05-11 | -$2.08K derived: sum of 2 quarters · filed 2026-05-11 | $14.57K derived: sum of 3 quarters · filed 2026-05-11 | $17.05K derived: sum of 4 quarters · filed 2026-05-11 | |
| 2024-12-31 | -$1.16K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $15.50K derived: sum of 2 quarters · filed 2026-03-26 | $17.98K derived: sum of 3 quarters · filed 2026-03-26 | $21.00K 10-K · filed 2026-03-26 | |
| 2024-09-30 | $16.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $19.13K derived: sum of 2 quarters · filed 2025-11-12 | $22.16K 10-Q · filed 2025-11-12 | $25.16K derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | $2.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $5.50K 10-Q · filed 2025-08-12 | $8.51K derived: sum of 3 quarters · filed 2025-08-12 | $10.87K derived: sum of 4 quarters · filed 2025-08-12 | |
| 2024-03-31 | $3.02K 10-Q · filed 2025-05-14 | $6.03K derived: sum of 2 quarters · filed 2025-05-14 | $8.39K derived: sum of 3 quarters · filed 2025-05-14 | $10.74K derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | $3.01K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $5.37K derived: sum of 2 quarters · filed 2025-03-27 | $7.72K derived: sum of 3 quarters · filed 2025-03-27 | $10.06K 10-K · filed 2025-03-27 | |
| 2023-09-30 | $2.36K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $4.71K derived: sum of 2 quarters · filed 2023-11-14 | $7.05K 10-Q · filed 2023-11-14 | $162.30K derived: sum of 4 quarters · filed 2024-03-26 | |
| 2023-06-30 | $2.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $4.69K 10-Q · filed 2023-08-10 | $159.94K derived: sum of 3 quarters · filed 2024-03-26 | ||
| 2023-03-31 | $2.34K 10-Q · filed 2023-05-12 | $157.59K derived: sum of 2 quarters · filed 2024-03-26 | |||
| 2022-12-31 | $155.25K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $2.90K 10-K · filed 2024-03-26 | |||
| 2022-09-30 | -$152.35K 10-Q · filed 2023-11-14 | ||||
| 2021-12-31 | -$403.94K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$50.23K derived: sum of 2 quarters · filed 2023-03-23 | -$42.05K derived: sum of 3 quarters · filed 2023-03-23 | -$33.98K 10-K · filed 2023-03-23 | |
| 2021-09-30 | $353.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $361.88K derived: sum of 2 quarters · filed 2022-11-10 | $369.96K 10-Q · filed 2022-11-10 | $366.20K 10-Q · filed 2021-11-12 | $399.85K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $8.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $16.25K 10-Q · filed 2022-08-08 | $46.14K derived: sum of 3 quarters · filed 2022-08-08 | ||
| 2021-03-31 | $8.07K 10-Q · filed 2021-05-10 | $37.96K derived: sum of 2 quarters · filed 2022-03-25 | |||
| 2020-12-31 | $29.89K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | $63.09K 10-K · filed 2022-03-25 | |||
| 2020-09-30 | $33.21K 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B |